FDA Issues Unsupported Safety Warning Regarding Surgical Robots for Cancer Treatment
FDA Law Blog
OCTOBER 14, 2021
Given these onerous requirements, it is not a surprise that RAS device manufacturers have not sought clearance for RAS devices for oncology procedures. It would also be beyond the scope of what RAS device manufacturers are intending to offer, which is a better surgical tool, not a therapeutic for cancer. 21 U.S.C. §
Let's personalize your content